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Introduction
Acetaminophen gained widespread popularity in the 1960s
as a less toxic, analgesic antipyretic agent than aspirin. Ironi-
cally, acetaminophen is now the second leading cause of
toxic drug ingestions in the United States [1]. Acetaminophen
toxicity is thus a real burden on our health care system, and
hepatotoxicity due to acetaminophen overdose has become
an important problem [2,3].
There are two distinct clinical syndromes described in litera-
ture. One is the ‘garden variety’, wherein the patients
ingested large amounts of acetaminophen with a suicidal
intent [4,5]. The other pattern is seen in chronic alcoholics
who ingest smaller amounts of acetaminophen in an attempt
to relieve pain [2,6–8]. Some cases of acetaminophen over-
dose have been described as parasuicidal, where the
attempted suicide is more of a gesture than an act of lethal
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intent. The aim of our study was to determine the epidemiol-
ogy of various types of acetaminophen poisoning and analyze
their outcome compared with their admission characteristics.
Methods
This study was conducted at Nassau University Medical Center
(East Meadow, NY, USA) which represents an urban county
hospital. Computer associated search was undertaken of all
admission records from January 1996 to April 1999. The
records of all the patients with a discharge diagnosis of aceta-
minophen overdose were analyzed. Patients who were not
admitted to the hospital after being assessed in the emergency
room were excluded from this study. We included patients who
had a history of acetaminophen ingestion reported by either the
patient or the family. We went on to confirm that the patient
had substantial acetaminophen ingestion by history, blood
acetaminophen level >10 mg/l, or serum aminotransferase level
>1000 IU/l. Two out of three of these conditions had to be met
for a case to be included in our study. Patients who had ele-
vated serum aminotransferase levels but in whom substantial
acetaminophen ingestion could not be adequately confirmed
were excluded from the study. Chronic alcohol abuse was
defined by the Diagnostic and Statistical Manual of Mental Dis-
orders 4th Edition (DSM-IV) criteria [9].
All of the patients with suicidal overdose were admitted to the
intensive care unit. For the patients with accidental aceta-
minophen ingestion, the triage was based on their clinical con-
dition. There was a standard management plan for all the
patients, as suggested by the National Poison Control Center.
Most of the patients were observed for 24 hours in the inten-
sive care unit before being transferred to the medical floor.
The following information was recorded: age; sex; race;
acetaminophen dose; reason for ingestion; history of alcohol
abuse or concurrent intoxication; time to presentation to the
emergency room since ingestion; and N-acetylcysteine
therapy. The laboratory data included peak acetaminophen
level, peak aminotransferase level, prothrombin time, serum
bilirubin, and serum creatinine. Using the International Classi-
fication of Diseases Ninth Revision (ICD-9) code [10], the
total number of cases of poisonings admitted during the
same time period was determined to calculate the prevalence
of acetaminophen toxicity.
Statistical analysis
The database used for recording the information was
Microsoft Access 6.0. Quantitative data was analyzed using
the Students unpaired t-test and the Mann–Whitney rank sum
test. Analysis of qualitative data was done using the Fisher
exact test and the chi-square test. Statistical analysis was
performed using Microsoft Excel 6.0.
Results
We identified 100 patients who had evidence of aceta-
minophen toxicity according to our criteria. Four patients had
to be excluded, because acetaminophen did not appear to
be the culprit for their clinical state. Three others were
excluded because they presented with another comorbid
condition that could have been responsible for their hepatic
profile. None of the patients who were excluded died during
their hospitalization.
Acetaminophen accounted for 7.5% of all cases of poisoning
admitted during this period. Of the 93 patients, 80 were clas-
sified as suicidal based on psychiatric evaluation, and 13 had
accidentally poisoned themselves in an attempt to relieve
pain. We could not identify any patients with parasuicidal
acetaminophen toxicity. The causes of chronic pain in the
accidental overdose group were toothache, chronic back-
ache, or headache. Eighty-eight of the 93 patients were
admitted to the intensive care unit for first 24–48 hours moni-
toring.
Table 1 shows that the patients with suicidal ingestion
tended to be younger than the accidental group. Female to
male ratio was 2:1, with a preponderance of whites in both
the groups. Chronic alcohol intake was more prevalent in the
accidental overdose subgroup.
It is evident that, although the peak acetaminophen level was
higher in the suicidal subgroup (mean 121.7 ± 97.0 vs
64.5 ± 61.8 mg/l,  P < 0.05), a peak aminotransferase level
>1000 IU/l was seen more frequently in the patients with acci-
dental overdose (39% vs 12%, P < 0.05) (Table 2). The renal
function was overall unaffected and not significantly different
between the two groups (data not shown). Morbidity and mor-
tality was higher in the accidental subgroup. There were only
two deaths, both in the accidental group; one of whom had a
Table 1
Characteristics of patients with acetaminophen overdose
Accidental Suicidal 
overdose overdose  P 
Characteristic (n = 13) (n = 80) value
Age (years)
Mean ± SD 35.4 ± 21.84 27 ± 15 < 0.05
Median 36 26
Range 1–88 12–75
Sex (n) 0.06
Female 5 54
Male 8 26
Race (n)N S
Asian 0 5
African American 3 13
Hispanic 0 8
White 10 54
Chronic alcohol abuse (n [%]) 5 (39) 15 (18) 0.10
Concurrent intoxication (n [%]) 3 (23) 36 (45) 0.20
NS, not significant.history of chronic alcohol abuse. N-acetylcysteine therapy was
given to 62% of the patients in the accidental group, com-
pared to 73% in the suicidal overdose group. The hospital
stay was higher in the accidental overdose group (mean
6.4 ± 6.1 days vs 3.9 ± 2.7 days, P < 0.01).
Discussion
This study did not take the dose of acetaminophen ingested
into consideration due to several reasons. Accurate dose
estimations could not be made in the accidental group
because many of these patients had inadvertent ingestion of
acetaminophen in more than one form over several days. The
other problem we faced was that some patients in the acci-
dental group were unaware of the presence of aceta-
minophen in some over-the-counter drugs. About 40% of the
patients in the suicidal group could not give an accurate
history about the dose of acetaminophen ingested. A sub-
stantial number of patients in the suicidal group were drowsy
and sedated due to other concomitant ingestions. Moreover,
most of the studies in the literature fail to demonstrate any
clear-cut, direct relationship between acetaminophen dose
and hepatotoxicity [6]. Low acetaminophen levels (<10 mg/l)
were found in 38% patients in the accidental group, com-
pared to 10% in the suicidal overdose group. This is probably
because these patients presented late, and they had ingested
small doses over a prolonged period.
Surprisingly, the morbidity and mortality were higher in the
accidental overdose group than the suicidal group (15% vs
0%, P < 0.05). There are two reasons for this. First, these
patients present late and sometimes the diagnosis is delayed,
both of which hinder optimal antidotal treatment. The second
reason could be the increased chronic alcohol use among the
accidental group (39% vs 12%, P < 0.05). However, the data
on the amount of alcohol, duration of intake, or interval
between intake of alcohol and acetaminophen are subject to
recall bias, withholding of information by the patient, or non-
responsive state of the patient on presentation.
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Table 2
Clinical variables seen in the suicidal and accidental overdose groups
Variable Accidental overdose (n = 13) Suicidal overdose (n = 80) P value
Presentation >24 hours after overdose (n/n studied [%]) 6/9 (66) 7/55 (13) < 0.001
Peak acetaminophen (mg/l)  < 0.050
Mean ± SD 64.5 ± 61.8 121.7 ± 97.0
Median 49 99
Range 0–184 0–439
Peak acetaminophen <10 mg/l (n [%]) 5 (38) 8 (10) NS
Peak ALT (IU/l) 0.070
Mean ± SD 1386 ± 1918 580 ± 1836
Median 187 30
Range 30–5584 30–10356
Peak AST (IU/l)  0.070
Mean ± SD 1330 ± 2697 504 ± 1708
Median 114 30
Range 30–9794 30–10773
Peak aminotransferase >1000 IU/l (n [%])  5 (39) 10 (12) < 0.050
Peak prothrombin time (seconds) < 0.050
Mean ± SD 15.6 ± 7.4 12.7 ± 2.1
Median 12 12
Range 12–35 12–25
Peak serum bilirubin (mg/dl) < 0.050
Mean 3.8 ± 5.5 1.3 ± 1.3
Median 1 1
Range 1–5 1–10
N-acetylcysteine therapy (n [%]) 8 (62) 59 (73) 0.500
Hepatic coma (n [%]) 2 (15) 0 (0) < 0.050
Death (n [%]) 2 (15) 0 (0) < 0.050
Length of stay in hospital (days) < 0.010
Mean 6.4 ± 6.1 3.9 ± 2.7
Median 4 3
Range 1–17 1–17The presumed basis for the potentiation of acetaminophen-
induced hepatotoxicity by chronic ethanol ingestion has
been amply discussed [11–14]. Elegant studies performed
in the early 1970s [15] established that acetaminophen,
taken in therapeutic doses, is metabolized by the liver
through two pathways. Most of the drug (80–90%) is conju-
gated with either glucuronic acid or sulphates, yielding the
nontoxic conjugates that are excreted by the kidney. A small
proportion (5%) is metabolized to a reactive electrophilic
intermediate by the cytochrome P-450 system. This metabo-
lite is rendered nontoxic by conjugation with glutathione to
form mercapturic acid and related conjugates that are also
excreted in the urine. If the drug is taken in excessive doses,
an augmented amount is converted by cytochrome P-450 to
the highly reactive, toxic intermediate metabolite [15,16]. It
then may reach a level that overwhelms the protective mech-
anism of glutathione conjugation and ultimately, through
covalent binding to hepatocyte proteins, leads to hepato-
cellular necrosis [17].
Therapeutic doses of acetaminophen have the potential of
producing liver damage if they are associated with circum-
stances that enhance the activity of the P-450 system leading
to increased production of toxic metabolite, or that interfere
with the protective mechanism by depleting the available glu-
tathione. Ethanol can potentiate damage due to both of these
reasons [11–14].
In the present study 6/9 (66%) patients in the accidental
overdose group and 7/55 (13%) in the suicidal overdose
group presented to the emergency room more than
24 hours after the overdose. N-acetylcysteine therapy was
given to 62% of the patients in the accidental group, com-
pared to 73% patients in the suicidal group. Treatment with
N-acetylcysteine has been very successful in preventing or
ameliorating hepatic injury after suicidal acetaminophen
overdose. However, the benefit of N-acetylcysteine in the
syndrome of acetaminophen injury as a therapeutic misad-
venture is not clearly defined. The final outcome in the case
of accidental overdose is dependent on a multitude of
factors, and thus a large number of cases will be required
for multivariate analysis to identify the role of N-acetylcys-
teine. As the efficacy of N-acetylcysteine as an antidote
decreases after eight hours, the treatment must be started
immediately following all potentially toxic doses of aceta-
minophen (>10 g). However, a large retrospective trial indi-
cated that N-acetylcysteine therapy decreased the
incidence of hepatotoxicity when administered up to
24 hours post overdose [18]. Patients, who have an
increased susceptibility to acetaminophen toxicity, particu-
larly alcoholics, should be considered for N-acetylcysteine
therapy at plasma levels that are half of those indicated in
the standard graph [19,20]. In addition, patients with acci-
dental overdose acquired over a number of hours should be
still considered for treatment, because in these cases
plasma levels are unreliable in predicting hepatotoxicity.
Our study also showed that, although patients with suicidal
overdose had higher peak acetaminophen levels than the
accidental overdose group, the peak aminotransferase level
(>1000 IU/L) was more often seen in the accidental over-
dose group (39% vs 12%, P < 0.05). The suicidal overdose
patients with high levels of liver enzymes more often had a
history of chronic alcohol abuse and they presented late.
Similar results have been reported in an Australian study [21].
Even when acute hepatic failure develops because of suicidal
overdose of acetaminophen, these patients have a good
prognosis in terms of liver transplantation and death.
[4,21–23]. In fact, none of our patients in the suicidal over-
dose group died or had to be referred for transplantation. In
contrast to this, in the accidental overdose group 2/13
patients developed fulminant hepatic failure leading to
hepatic coma and ultimately to death. Thus peak aceta-
minophen levels correlate poorly with hepatic dysfunction,
morbidity and mortality.
The number of days of hospitalization was higher in the acci-
dental group. There are numerous studies which have shown
that the total cost of treating a patient in the intensive care
unit in the US is approximately $25,000–35,000 per day
[24,25]. It is a tradition in many hospitals in the country to
admit patients with acetaminophen overdose to critical care
units. In our study, out of the 80 patients in the suicidal group,
75 were admitted to the intensive care unit, whereas all the
13 patients in the accidental overdose group were admitted
to this unit. Because of their benign clinical course, we rec-
ommend that patients with suicidal acetaminophen overdose
can be safely managed on the medical floors unless there is a
history of chronic alcohol abuse or other concomitant poison-
ings. In our hospital this would translate to a cost saving of at
least $500,000 per year.
Conclusion
In summary, acetaminophen poisoning continues to remain a
significant reason for hospital admissions among young
adults. Peak acetaminophen levels correlate poorly with the
clinical course. The admission of the patients to the intensive
care unit or ward should be determined by the degree of
derangement of their clinical parameters. Patients with suicidal
overdose and no history of chronic alcohol use do not need be
admitted to the intensive care unit. This excludes patients for
whom there is any doubt about the history of chronic alcohol
abuse and those who have accidentally poisoned themselves.
These are the patients who have an unfavorable clinical
course and should be monitored in a critical care setting.
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